ARCHIVES

Banned Investigator Plans To Resume Clinical Trials Role

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

U.S. Cigarette Sales Dropped 4.2 Percent Last Year

March 31, 2006

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994